⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KVUE News
Kenvue Inc.
Essity acquires feminine care business in Brazil
prnewswire.com
KVUE
Essity acquires feminine care business in Brazil
prnewswire.com
KVUE
ZYRTEC® Launches New Drug-Free Allergen Shield Spray, a Breakthrough for Proactive Everyday* Allergen Defense
prnewswire.com
KVUE
Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel
prnewswire.com
KMB
KVUE
Form 8-K
sec.gov
KVUE
FDA Approves TYLENOL® with Naproxen, the First and Only Over-the-Counter Fixed-Dose Combination of Acetaminophen (650 mg) and Naproxen Sodium (220 mg)
prnewswire.com
KVUE
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026
businesswire.com
KVUE
Neutrogena® Announces 'Break the Rules,' a New Brand Mission Empowering Consumers to Break Beauty's Rules with Science
prnewswire.com
KVUE
Kenvue, Maker of Neutrogena(R), Aveeno(R), OGX(R), and Zyrtec(R), Beats 2025 Packaging Goal, Demonstrates Continued Progress With More Sustainable Innovation
accessnewswire.com
KVUE
Women Leaders Take Centre Stage at Procurement LIVE: The London Summit This September
globenewswire.com
V
KVUE